Polyplus now part of Sartorius
Entity

  • Polyplus now part of Sartorius

    Created in 2001
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    249 10,701 10,701

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    SMB

  • Location

    75 Rue Marguerite Perey, 67400 Illkirch-Graffenstaden, France

    Illkirch-Graffenstaden

    France

  • Employees

    Scale: 51-200

    Estimated: 117

  • SIREN

    434320479

  • Engaged corporates

    4
    3 1

  • Added in Motherbase

    4 years, 1 month ago
Description
  • Value proposition

    We power your science

    Polyplus, now part of Sartorius is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States and Asia.

    Research, DNA, Transfection, Gene expression, Bioproduction, Life sciences, Biotechnology, RNA interference, Science, Biology, Protein production, Virus production, Cell culture, CRISPR, and Biotechnology

  • Original language

    We power your science

    Polyplus, now part of Sartorius is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States and Asia.

  • Polyplus® | Expertise - Quality - Support

    Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services.

    • https://www.polyplus-sartorius.com/
Corporate interactions BETA
Corporate TypeTweets Articles
SEMIA
SEMIA
Startup accelerator & VC, Business Consulting and Services
SEMIA
Startup accelerator & VC, Business Consulting and Services 		Other

8 Apr 2023


SATT CONECTUS
SATT CONECTUS
Research, Research Services
SATT CONECTUS
Research, Research Services 		Other

3 Apr 2023


Regeneron
Regeneron
Pharmaceutical, Biotechnology, Biotechnology Research
Regeneron
Pharmaceutical, Biotechnology, Biotechnology Research 		Other

21 Feb 2023


La French Tech Est
La French Tech Est
Startup accelerator & VC, French Tech, Business Consulting and Services
La French Tech Est
Startup accelerator & VC, French Tech, Business Consulting and Services 		Not capitalistic
Not partnership
Event

4 Jun 2018


Similar entities
Last news
Show all articles
Social network dynamics